Auro-Repaglinide 0.5 mg (Repaglinide TABLET) 0.5 MG

AURO-REPAGLINIDE 0.5 MG tablets are an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This prescription drug helps control glucose by stimulating insulin release from the pancreas.

Strength

0.5 MG

Pack Size

30/100/500/1000

Manufacturer / TM Owner

AURO PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Repaglinide is primarily used to lower blood sugar levels in adults with type 2 diabetes. It works by stimulating the pancreas to produce more insulin in response to meals. This medication is often prescribed as part of a broader diabetes management plan, which may include diet and exercise. People often ask, 'What is repaglinide used for?' It is typically used to help control blood sugar levels when diet and exercise alone are not sufficient.

Side Effects

Common effects of repaglinide may include mild to moderate side effects such as headache, dizziness, and nausea. Some users may experience low blood sugar (hypoglycemia), especially if meals are skipped or delayed. It's important to monitor blood sugar levels regularly while taking this medication.

Precautions & Warnings

Repaglinide should be handled with care, especially for those with a history of liver or kidney problems. It is important to follow the prescribed dosage and timing, typically taken before meals. Always consult a healthcare provider before starting or stopping this medication. Keep this medication out of reach of children and store it as directed.

Avoid Interactions

Repaglinide may interact with other medications, including those that affect blood sugar levels or are metabolized by the liver. Alcohol can also interact with repaglinide, potentially increasing the risk of low blood sugar. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Repaglinide is used to manage blood sugar levels in adults with type 2 diabetes by stimulating insulin release from the pancreas.

Repaglinide is typically taken orally before meals. Follow the dosage and timing as prescribed by your healthcare provider.

Common side effects may include headache, dizziness, nausea, and low blood sugar (hypoglycemia).

Repaglinide may interact with other medications, so it's important to consult your healthcare provider before combining it with other drugs.

Repaglinide should be used with caution in individuals with liver or kidney problems. Always consult a healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.